gastric cancer
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
gastric cancer
Jul 20, 2024, 21:29 |
Insight
Harry Sokol: The role of Faecali bacterium prausnitzii to boost ICI efficacy in cancer
Sumanta K. Pal shared a post by Harry Sokol, Professor of Gastroenterology at Greater Paris…
Jul 17, 2024, 01:28 |
Blog
Florian Lordick: Outstanding 15th APCG 10th SGCC Gastric Cancer Meeting
Florian Lordick, Editor in Chief - ESMO Gastrointestinal Oncology at ESMO, shared a post on…
Jul 15, 2024, 04:26 |
Blog
Florian Lordick: 15th APGCC 10th SGCC scientific meeting on Gastric Cancer
Florian Lordick, Director of Education at ESMO, shared on LinkedIn: "Impressions from the 15th APGCC…
Jul 14, 2024, 06:51 |
Blog
Angelica Petrillo: The value of PD-L1 in Gastric Cancer
Angelica Petrillo, Medical Doctor at the Medical Oncology Unit at Ospedale del Mare in Naples,…
Jul 10, 2024, 03:31 |
Blog
Bilal Alkhaffaf: Healthcare professionals have a responsibility to ensure that resources are used effectively
Bilal Alkhaffaf, Consultant Oesophago-Gastric and Bariatric Surgeon at NHS, shared on LinkedIn: "As healthcare professionals involved…
Jul 7, 2024, 07:08 |
Insight
Medigene AG Expands Patent Portfolio with the Patent Grant for NY-ESO-1/LAGE 1a Targeted T Cell Receptor in China
Medigene AG, an immuno-oncology platform company focusing on the discovery and development of T cell…
Jul 4, 2024, 11:21 |
Blog
Florian Lordick: New first-line treatment algorithm for advanced gastric cancer published in ESMO
Florian Lordick, Director of Education at ESMO, shared on LinkedIn: "New first-line treatment algorithm for…
Jul 3, 2024, 02:47 |
Societies
Seyed Alireza Javadinia: Oesophago-gastric cancer on the third day of ESMOGI24
Seyed Alireza Javadinia, Clinical Oncologist at Sabzevar University of Medical Sciences, shared on LinkedIn: "Oesophago-gastric…
Jun 29, 2024, 13:50 |
Drugs
Chemotherapy with adjuvant nivolumab versus placebo for GEJ cancer
Syed A. Ahmad, Chief of Surgical Oncology at The University of Cincinnati, made the following…
Jun 27, 2024, 13:40 |
Insight
New study on germline CDH1 variants shows lifetime cancer risks
Yüksel Ürün shared on X: "New study on germline CDH1 variants shows lifetime cancer risks:…
Jun 23, 2024, 14:51 |
Blog
Pedro C Barata: Founder mutation CDH1 in Portugal and gastric cancer
Pedro C Barata, GU Med Oncologist at University Hospitals Seidman Cancer Center, posted on X:…
Jun 21, 2024, 07:54 |
Insight
New Paper Alert! New Study Reveals Lower than Expected Gastric Cancer Risk for CDH1 Mutation Carriers
New Study Reveals Lower than Expected Gastric Cancer Risk for CDH1 Mutation Carriers Authors: Carrie…
Jun 17, 2024, 12:11 |
Cancer Types
Stomach cancer: What patients should know about
Introduction, what is stomach cancer Stomach cancer, also known as gastric cancer, is a type…
Jun 8, 2024, 08:22 |
Blog
Michel Ducreux and Teresa Macarulla discussing GI Cancer research on ESMO Daily Reporter
ESMO shared on LinkedIn: "Whilst neoadjuvant chemotherapy is now a well-established strategy for treating some…
May 26, 2024, 16:38 |
Blog
Zouina Sarfraz: Two of my abstracts have been published for the 2024 ASCO Annual Meeting
Zouina Sarfraz, Associate Editor at BMC, shared a post on LinkedIn: "I am pleased to announce…
May 19, 2024, 05:52 |
Insight
Ahmed Abdelhakeem: Our meta-analysis on survival in stage IV gastric cancer patients with ovarian metastases
Ahmed Abdelhakeem, Chief Resident at Baptist Hospitals of Southeast Texas, shared on X: "New Publication…
May 16, 2024, 16:51 |
Insight
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
In the fast-growing field of oncology, we are witnessing significant advances in several treatment modalities…
May 10, 2024, 17:49 |
Drugs
Piotr Wysocki: Relatlimab does not improve the activity of nivolumab plus chemotherapy
Piotr Wysocki recently posted on LinkedIn: "RELATIVITY-060 was an open-label phase II study investigating the…
May 2, 2024, 15:20 |
Blog
Paolo Tarantino: Impressive to think at the journey of ADCs over the last five years
Paolo Tarantino shared on LinkedIn: "Impressive to think at the journey of ADCs over the last…
Apr 30, 2024, 07:31 |
Insight
Top 5 posts of the week by Cancer Network
Cancer Network shared on their X/Twitter page: "View our top 5 posts of the week:…
Apr 22, 2024, 11:11 |
Insight
New Paper Alert! Impact of Pathological Complete Response on Long-Term Survival in Locally Advanced Gastric Cancer Patients Treated with Neoadjuvant Chemotherapy
Impact of Pathological Complete Response on Long-Term Survival in Locally Advanced Gastric Cancer Patients Treated…
Apr 20, 2024, 08:16 |
Blog
Tanja Obradovic: One exciting novel approach is just about to enter clinical development
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON plc, shared a post on LinkedIn: "Cell…
Apr 16, 2024, 01:34 |
Insight
Arndt Vogel: Prognostic and predictive impact of sex in locally advanced Microsatellite instability (MSI) gastric or gastroesophageal junction cancer
Arndt Vogel, Managing Senior Consultant and Professor in the Department of Gastroenterology, Hepatology and Endocrinology…
Apr 15, 2024, 16:32 |
Blog
Yelena Janjigian at the Oncology Congress!
Yelena Janjigian shared a post on X: “Our mission Memorial Sloan Kettering Cancer Center is…
Apr 15, 2024, 13:00 |
Insight
Sumanta K. Pal: Nice paper from Yanghee Woo's group
Sumanta K. Pal, Co-director of City of Hope's Kidney Cancer Program, shared a post on…
Apr 11, 2024, 16:08 |
Insight
New Paper Alert! Exploring the Genomic Diversity of Cancer in Latin American Populations
Exploring the Genomic Diversity of Cancer in Latin American Populations Authors: Alejandro Ruíz-Patiño, Leonardo Rojas,…
Apr 11, 2024, 14:45 |
Insight
Wafik El-Deiry: Susan Galbraith speaks about AstraZeneca oncology portfolio and collaboration opportunities at the AACR Oncology Industry Partnering Event in San Diego
Wafik El-Deiry, Director of the Legorreta Cancer Center at Brown University, recently posted on LinkedIn:…
Apr 3, 2024, 15:36 |
Blog
Adam Yopp: Sam C. Wang, the epitome of a surgeon-scientist, recently awarded second NIH R01 grant studying gastric cancer
Adam Yopp, Liver Surgeon at UT Southwestern Medical Center, shared a post on X/Twitter: "Sam…
Mar 26, 2024, 15:10 |
Blog
Yelena Janjigian: We are meeting and reviewing the candidates now for Debbies Dream Foundation Gastric Cancer Investigator Fellowship
Yelena Janjigian shared a post by Debbie's Dream Foundation on X, adding: "We are meeting and reviewing…
Mar 11, 2024, 03:11 |
Blog
Herbert Loong: A privilege to participate and co-chair an informative event held at Amgen Oncology in Kuala Lumpur
Herbert Loong, Clinical Associate Professor at the Chinese University of Hong Kong, shared on X/Twitter:…
Feb 27, 2024, 05:27 |
Blog
Shubh Goel: Recently, I spoke to a Pharmaceutical Executive following data presented at ASCO GI from our EMERALD-1 and MATTERHORN Phase III trials
Shubh Goel, VP and US Franchise Head, Immuno-Oncology and GI Tumors at AstraZeneca, shared a…
Feb 14, 2024, 14:59 |
Blog
Yelena Janjigian is leading the investigator-initiated trial of the First Novel Combination of MiNK's Allogeneic Cell Therapy with Agenus' BOT/BAL
Today MiNK Therapeutics released an announcement of the First Refractory Gastric Cancer Patient Dosed in…
Feb 6, 2024, 14:34 |
Blog
Potential of iNKT cells to combat resistance to immune checkpoint inhibitors - MiNK Therapeutics
Quoting MiNK Therapeutics on LinkedIn: "New publication in Oncogene spotlights a compelling case study of…
Jan 29, 2024, 03:56 |
Insight
Myriam Chalabi: The Phase 2 PANDA Trial is out in Nature Medicine
Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher at Antoni van Leeuwenhoek, The Netherlands Cancer…
Oct 24, 2023, 15:36 |
Blog
Lucjan Wyrwicz: Grab the most recent issue of the Lancet Oncology with the full report of the Keynote-859 study
Lucjan Wyrwicz, Professor at the National Institute of Oncology Maria Skłodowska-Curie - National Research Institute,…
Sep 21, 2023, 18:35 |
Stories
Carol Beth Anderson: I'd like to talk about one of the hard things about a journey like this...
Quoting Carol Beth Anderson on X/Twitter: ''Four months ago yesterday, my husband was diagnosed with…
Sep 19, 2023, 18:34 |
Insight
Lucjan Wyrwicz: Proud to be the senior author of this important study...
Lucjan Wyrwicz, medical oncologist from Maria Curie National Cancer Research Institute in Warsaw, Poland, recently…
All:
37
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube